Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation

Pharmacology
E TatouL Rochette

Abstract

Cyclosporin A (CsA) is widely used as the immunosuppressant of choice for preventing graft rejection. However, its clinical use is hampered by certain side effects, especially its nephrotoxicity and other cardiovascular side effects. CsA for intravenous infusion contains cremophor (Cre) and this vehicle has significant adverse effects on endothelial function and vascular muscle. The present study was aimed at investigating the direct effects of CsA and Cre on isolated and perfused rat hearts in the dosage that closely approximates the peak level achieved for the prevention of graft rejection in the rat. Transplantation is a clinical setting in which the myocardium may be exposed to transient ischemia. In this study, we have shown that the vehicle of CsA, namely Cre, has significant adverse effects on cardiac function. We observed a reduction in coronary flow and aortic output. Addition of CsA appeared to induce a further reduction of aortic flow. We have also shown that a significant increase of thiobarbituric acid reactive substances, considered as an index of lipid peroxidation, occurred in the reperfused heart in the presence of Cre+CsA. Our experimental study shows that Cre turned out to be toxic to myocardium by itself. In...Continue Reading

Citations

May 24, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jing ZengXiabin Jing
Jul 20, 2000·Journal of Neuroimmunology·L CaoJ N Whitaker
Apr 12, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Mu, S S Feng
Jul 8, 2003·Clinical Pharmacokinetics·Albert J ten TijeAlex Sparreboom
Mar 21, 2000·Journal of Molecular and Cellular Cardiology·H SanchezR Ventura-Clapier
May 4, 2004·Journal of Colloid and Interface Science·Lingyun Zhao, Si-Shen Feng
Jul 3, 2015·Biological & Pharmaceutical Bulletin·Sang Duk HanMyung Joo Kang
Dec 20, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Mu, S S Feng
May 12, 2010·Acta Anaesthesiologica Scandinavica·R H LieT T Nielsen
Aug 29, 2014·International Journal of Toxicology·Christina L BurnettF Alan Andersen
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Claus U NiemannNatalie Serkova
Aug 5, 2000·The Annals of Pharmacotherapy·F A LoVecchio, H R Goltz
May 17, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·Lars O KarlssonLars Grip

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.